Vitamin D, Epigallocatechin Gallate, D-chiro-inositol and Vitamin B6 in Uterine Fibroid
The Use of Vitamin D in Combination With Epigallocatechin Gallate, D-chiro-inositol and Vitamin B6 in the Treatment of Women With Uterine Fibroid
Lo.Li.Pharma s.r.l
60 participants
Jul 1, 2022
INTERVENTIONAL
Conditions
Summary
The study will evaluate the impact on uterine fibroids' volume of a combination of natural molecules including Epigallocatechin gallate, Vitamin D, D-chiro-inositol and Vitamin B6. The patients will be evaluated at baseline and after three months of treatment with placebo or product.
Eligibility
Inclusion Criteria3
- uterine fibroid with diameter greater than or equal to 4cm or multiple fibroids
- eligible for surgery
- symptoms like menometrorrhagia or pelvic pain
Exclusion Criteria5
- BMI\>30
- currently pregnant or breastfeeding
- diabetic
- suspect of malignancy
- diagnosis of cancer
Interventions
The patients will take for three months two tablets per day each containing 150mg epigallocatechin gallate, 25 mg D-chiro-inositol, 5mg Vitamin B6 and 25μg Vitamin D
Maltodextrines
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05448365